Increase in Lipoprotein Lipase during Clofibrate Treatment of Hypertriglyceridemia in Patients on Hemodialysis
- 15 November 1979
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 301 (20) , 1073-1076
- https://doi.org/10.1056/nejm197911153012001
Abstract
In 11 hypertriglyceridemic patients on hemodialysis, clofibrate (1 to 1.50 g per week) reduced plasma triglyceride (-40±20 per cent, Ps = 0.792, Ps = 0.851, Ps = 0.696, Ps = 0.679, P<0.10). There was no correlation between changes in hepatic triglyceride lipase activity and plasma lipids during treatment.This publication has 22 references indexed in Scilit:
- Postheparin plasma triglyceride lipases in chronic hemodialysis: Evidence for a role for hepatic lipase in lipoprotein metabolismMetabolism, 1979
- Heparin Pharmacokinetics: Increased Requirements in Pulmonary EmbolismBritish Journal of Haematology, 1978
- Prevalence of serum lipid abnormalities in chronic hemodialysisMetabolism, 1977
- High density lipoprotein as a protective factor against coronary heart diseaseThe American Journal of Medicine, 1977
- Control of clofibrate toxicity in uremic hypertriglyceridemiaClinical Pharmacology & Therapeutics, 1977
- An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasmaClinica Chimica Acta; International Journal of Clinical Chemistry, 1975
- Hyperlipidemia in Coronary Heart Disease I. LIPID LEVELS IN 500 SURVIVORS OF MYOCARDIAL INFARCTIONJournal of Clinical Investigation, 1973
- ISCHÆMIC HEART-DISEASE IN RELATION TO FASTING VALUES OF PLASMA TRIGLYCERIDES AND CHOLESTEROLThe Lancet, 1972
- HypertriglyceridemiaNew England Journal of Medicine, 1968
- Serial Studies on the Metabolism of Human Adipose Tissue. I. Lipogenesis and Free Fatty Acid Uptake and Release in Small Aspirated Samples of Subcutaneous Fat *Journal of Clinical Investigation, 1964